Study HZA106829: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to compare the efficacy and safety of fluticasone
furoate/vilanterol (GW642444) inhalation powder administered once daily each evening with
fluticasone furoate inhalation powder administered alone once daily each evening in
adolescent and adult subjects 12 years of age and older with persistent bronchial asthma over
a 24-week period.